602.90
price down icon2.84%   -17.61
 
loading
Medpace Holdings Inc stock is traded at $602.90, with a volume of 219.12K. It is down -2.84% in the last 24 hours and up +1.96% over the past month. Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
See More
Previous Close:
$620.51
Open:
$624.86
24h Volume:
219.12K
Relative Volume:
0.79
Market Cap:
$16.83B
Revenue:
$2.68B
Net Income/Loss:
$460.40M
P/E Ratio:
37.93
EPS:
15.8963
Net Cash Flow:
$711.00M
1W Performance:
-3.09%
1M Performance:
+1.96%
6M Performance:
+21.55%
1Y Performance:
+13.69%
1-Day Range:
Value
$601.36
$642.64
1-Week Range:
Value
$587.38
$642.64
52-Week Range:
Value
$373.00
$677.90

Medpace Holdings Inc Stock (MEDP) Company Profile

Name
Name
Medpace Holdings Inc
Name
Phone
(513) 579-9911
Name
Address
5375 MEDPACE WAY, CINCINNATI, OH
Name
Employee
6,300
Name
Twitter
@WorkatMedpace
Name
Next Earnings Date
2026-10-21
Name
Latest SEC Filings
Name
MEDP's Discussions on Twitter

Compare MEDP vs TMO, DHR, NTRA, A, WAT

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
MEDP icon
MEDP
Medpace Holdings Inc
602.90 17.27B 2.68B 460.40M 711.00M 15.90
TMO icon
TMO
Thermo Fisher Scientific Inc
656.58 241.26B 45.20B 6.87B 6.75B 18.19
DHR icon
DHR
Danaher Corp
215.61 150.48B 24.78B 3.68B 5.29B 5.1743
NTRA icon
NTRA
Natera Inc
400.65 59.47B 2.50B -226.32M 71.51M -1.6412
A icon
A
Agilent Technologies Inc
169.33 48.71B 7.23B 1.41B 1.09B 4.979
WAT icon
WAT
Waters Corp
436.43 42.59B 3.77B 449.25M 240.68M 7.8556

Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-06-26 Upgrade Barclays Underweight → Equal Weight
Mar-03-26 Initiated RBC Capital Mkts Outperform
Feb-18-26 Upgrade TD Cowen Sell → Hold
Feb-13-26 Upgrade Jefferies Hold → Buy
Feb-10-26 Upgrade Robert W. Baird Neutral → Outperform
Nov-13-25 Initiated BMO Capital Markets Market Perform
Oct-02-25 Downgrade Barclays Equal Weight → Underweight
Sep-03-25 Downgrade Rothschild & Co Redburn Buy → Neutral
Jul-29-25 Downgrade UBS Neutral → Sell
Jul-23-25 Downgrade TD Cowen Hold → Sell
Jun-24-25 Initiated Barclays Equal Weight
Apr-22-25 Downgrade William Blair Outperform → Mkt Perform
Apr-14-25 Downgrade TD Cowen Buy → Hold
Mar-24-25 Initiated Leerink Partners Market Perform
Oct-23-24 Downgrade Robert W. Baird Outperform → Neutral
Oct-14-24 Initiated Redburn Atlantic Buy
Sep-27-24 Downgrade UBS Buy → Neutral
Sep-25-24 Downgrade Jefferies Buy → Hold
Aug-01-24 Initiated Truist Hold
May-29-24 Initiated TD Cowen Buy
May-28-24 Initiated Mizuho Buy
Apr-23-24 Upgrade Jefferies Hold → Buy
Mar-18-24 Initiated Deutsche Bank Hold
Feb-15-24 Upgrade UBS Neutral → Buy
Oct-24-23 Upgrade Robert W. Baird Neutral → Outperform
May-08-23 Upgrade Guggenheim Neutral → Buy
Oct-27-22 Upgrade UBS Sell → Neutral
Sep-07-22 Initiated UBS Sell
May-24-22 Initiated Guggenheim Neutral
Aug-05-21 Resumed Credit Suisse Outperform
Oct-02-20 Upgrade Truist Hold → Buy
Jun-08-20 Upgrade Robert W. Baird Underperform → Neutral
May-13-20 Downgrade Wolfe Research Outperform → Peer Perform
Apr-30-20 Upgrade SunTrust Sell → Hold
Apr-20-20 Downgrade Robert W. Baird Neutral → Underperform
Mar-17-20 Downgrade SunTrust Hold → Sell
Jan-27-20 Downgrade SunTrust Buy → Hold
Oct-31-18 Upgrade SunTrust Hold → Buy
Sep-17-18 Initiated SunTrust Hold
Jul-31-18 Upgrade William Blair Mkt Perform → Outperform
Nov-01-17 Downgrade William Blair Outperform → Mkt Perform
Sep-29-17 Initiated Raymond James Mkt Perform
Jul-10-17 Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
View All

Medpace Holdings Inc Stock (MEDP) Latest News

pulisher
Oct 01, 2026

Medpace Holdings, Inc. (MEDP) Stock Forecasts - Yahoo Finance

Oct 01, 2026
pulisher
Sep 30, 2026

UBS Initiates Medpace(MEDP.US) With Hold Rating, Announces Target Price $673 - Moomoo

Sep 30, 2026
pulisher
Sep 30, 2026

UBS Upgrades Medpace Holdings to Neutral From Sell, Adjusts Price Target to $673 From $405 - Moomoo

Sep 30, 2026
pulisher
Sep 30, 2026

Enterprise value to EBIT forward of Medpace Holdings, Inc. – HAN:01P - TradingView

Sep 30, 2026
pulisher
Sep 30, 2026

Here's How Much $100 Invested In Medpace Holdings 10 Years Ago Would Be Worth Today - Benzinga

Sep 30, 2026
pulisher
Sep 30, 2026

Insider Decision: August J Troendle Offloads $1.59M Worth Of Medpace Holdings Stock - Benzinga

Sep 30, 2026
pulisher
Sep 30, 2026

Long term debt to total assets ratio of Medpace Holdings, Inc. – HAN:01P - TradingView

Sep 30, 2026
pulisher
Sep 30, 2026

Medpace stock coverage resumed at UBS with neutral rating - Investing.com

Sep 30, 2026
pulisher
Sep 30, 2026

UBS Initiates Coverage of Medpace (MEDP) with Neutral Rating and $673 Price Target - GuruFocus

Sep 30, 2026
pulisher
Sep 29, 2026

Medpace (MEDP) Rises As Market Takes a Dip: Key Facts - Yahoo Finance

Sep 29, 2026
pulisher
Sep 29, 2026

Medpace Holdings Insider Sold Shares Worth $1,589,941, According to a Recent SEC Filing - marketscreener.com

Sep 29, 2026
pulisher
Sep 29, 2026

At about $620 a share, Medpace (MEDP) CEO sells stock on two dates: 2,410 shares and 154 shares - Stock Titan

Sep 29, 2026
pulisher
Sep 28, 2026

Form 13D/A Medpace Holdings For: 28 September By Investing.com - Investing.com Nigeria

Sep 28, 2026
pulisher
Sep 27, 2026

Medpace Holdings CEO August J. Troendle sells $6.75m in stock - Investing.com

Sep 27, 2026
pulisher
Sep 27, 2026

Medpace Holdings CEO August J. Troendle sells $6.75m in stock By Investing.com - Investing.com South Africa

Sep 27, 2026
pulisher
Sep 27, 2026

Medpace Holdings CEO August Troendle sells $44.4m stock - Investing.com

Sep 27, 2026
pulisher
Sep 27, 2026

Medpace Holdings CEO August Troendle sells $44.4m stock By Investing.com - Investing.com South Africa

Sep 27, 2026
pulisher
Sep 27, 2026

Form 4 Medpace Holdings Inc For: 27 September By Investing.com - Investing.com Nigeria

Sep 27, 2026
pulisher
Sep 26, 2026

Form 4 Medpace Holdings Inc For: 26 September By Investing.com - Investing.com Canada

Sep 26, 2026
pulisher
Sep 26, 2026

Medpace CEO August Troendle sells $27.4m in company stock - Investing.com

Sep 26, 2026
pulisher
Sep 26, 2026

Medpace CEO August Troendle sells $27.4m in company stock By Investing.com - Investing.com South Africa

Sep 26, 2026
pulisher
Sep 26, 2026

Form 4 Medpace Holdings Inc For: 26 September - Investing.com India

Sep 26, 2026
pulisher
Sep 25, 2026

CEO sells shares on two days at Medpace (MEDP); a separate entry lists 4,733,019 indirectly held shares. - Stock Titan

Sep 25, 2026
pulisher
Sep 24, 2026

Medpace Holdings, Inc. (MEDP) Stock forecasts - uk.finance.yahoo.com

Sep 24, 2026
pulisher
Sep 24, 2026

Insider Transaction: August J Troendle Sells $44.43M Worth Of Medpace Holdings Shares - Benzinga

Sep 24, 2026
pulisher
Sep 24, 2026

Have Insiders Sold Medpace Holdings Shares Recently? - simplywall.st

Sep 24, 2026
pulisher
Sep 24, 2026

After a 13,059-share sale, August Troendle reports a stake in Medpace (MEDP). - Stock Titan

Sep 24, 2026
pulisher
Sep 24, 2026

Medpace stock falls 2.07 percent as CEO sale surfaces - AD HOC NEWS

Sep 24, 2026
pulisher
Sep 23, 2026

Medpace(MEDP.US) 10% Shareholder Sells US$44.43 Million in Common Stock - moomoo.com

Sep 23, 2026
pulisher
Sep 23, 2026

Medpace (MEDP) CEO sold 49,018 shares on Sept. 22 at a $628.11 average price. - Stock Titan

Sep 23, 2026
pulisher
Sep 23, 2026

MEDP FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important June 8 Deadline in Securities Class ActionMEDP - TMX Newsfile

Sep 23, 2026
pulisher
Sep 22, 2026

Mizuho maintains Outperform on Medpace, raises target to $586 - scanx.trade

Sep 22, 2026
pulisher
Sep 22, 2026

Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026 - Investing News Network

Sep 22, 2026
pulisher
Sep 22, 2026

Medpace Holdings Q3FY26 Results: Earnings call set for Oct 22 - scanx.trade

Sep 22, 2026
pulisher
Sep 22, 2026

Medpace Holdings President & CEO Trades $6.75M In Company Stock - Benzinga

Sep 22, 2026
pulisher
Sep 22, 2026

Projected EPS and Revenue Gains Might Change The Case For Investing In Medpace Holdings (MEDP) - Yahoo Finance

Sep 22, 2026
pulisher
Sep 21, 2026

Medpace Holdings (MEDP) Nears Earnings, Is The Stock Fully Valued? - Yahoo Finance

Sep 21, 2026
pulisher
Sep 21, 2026

Medpace Holdings Insider Sold Shares Worth $6,749,952, According to a Recent SEC Filing - moomoo.com

Sep 21, 2026
pulisher
Sep 21, 2026

Medpace (MEDP) Outperforms Broader Market: What You Need to Know - Yahoo Finance

Sep 21, 2026
pulisher
Sep 21, 2026

Medpace (NASDAQ:MEDP) CEO Sells $6,749,952.00 in Stock - MarketBeat

Sep 21, 2026
pulisher
Sep 21, 2026

Medpace (NASDAQ: MEDP) CEO sells shares, holds 504,273 directly - Stock Titan

Sep 21, 2026
pulisher
Sep 20, 2026

Medpace Holdings, Inc. (MEDP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Sep 20, 2026
pulisher
Sep 18, 2026

Medpace Holdings, Inc.Common Stock (Nasdaq:MEDP) Price Chart - The Chronicle-Journal

Sep 18, 2026
pulisher
Sep 18, 2026

Medpace Holdings President & CEO Sold $15.36M In Company Stock - Benzinga

Sep 18, 2026
pulisher
Sep 17, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Medpace Holdings, Inc. (MEDP) And Encourages Shareholders to Connect - ACCESS Newswire

Sep 17, 2026
pulisher
Sep 17, 2026

Medpace Holdings (MEDP) CEO sells stock in two $620-range trades - Stock Titan

Sep 17, 2026
pulisher
Sep 17, 2026

Medpace Holdings (MEDP) insider exercises 3,000 options - Stock Titan

Sep 17, 2026
pulisher
Sep 17, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Medpace Holdings, Inc. (MEDP) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Sep 17, 2026
pulisher
Sep 16, 2026

Medpace (MEDP) Retreats -0.57%, Breaching $586.11 Support Line 2026-09-16Bearish Sentiment - careplusvn.com

Sep 16, 2026
pulisher
Sep 16, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Medpace Holdings, Inc. (MEDP), Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Sep 16, 2026
pulisher
Sep 15, 2026

Medpace Holdings Inc (MEDP) Stock Up 4.1% but GF Value Says Over - GuruFocus

Sep 15, 2026

Medpace Holdings Inc Stock (MEDP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Medpace Holdings Inc Stock (MEDP) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Troendle August J.
President & CEO
Sep 30 '26
Sale
625.47
21,966
13,739,074
338,225
Troendle August J.
President & CEO
Sep 28 '26
Sale
620.07
2,410
1,494,369
386,892
Troendle August J.
President & CEO
Sep 25 '26
Sale
620.60
154
95,572
389,302
Troendle August J.
President & CEO
Sep 24 '26
Sale
621.33
27,833
17,293,478
389,456
Troendle August J.
President & CEO
Sep 23 '26
Sale
628.64
16,083
10,110,417
417,289
Troendle August J.
President & CEO
Sep 22 '26
Sale
628.11
49,018
30,788,696
433,372
Troendle August J.
President & CEO
Sep 21 '26
Sale
623.29
21,883
13,639,455
482,390
Troendle August J.
President & CEO
Sep 17 '26
Sale
620.40
10,880
6,749,952
504,273
Troendle August J.
President & CEO
Sep 15 '26
Sale
620.84
15,971
9,915,436
523,923
Troendle August J.
President & CEO
Sep 16 '26
Sale
621.29
8,770
5,448,713
515,153
LH LH
$311.71
price up icon 0.99%
MTD MTD
$1,533.07
price down icon 0.56%
$515.41
price down icon 2.21%
$273.54
price down icon 6.86%
IQV IQV
$259.98
price down icon 2.30%
WAT WAT
$436.43
price down icon 0.84%
Cap:     |  Volume (24h):